Related Articles
Plasma sphingolipids: Potential biomarkers for severe hepatic fibrosis in chronic hepatitis C
Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C
Progress in evaluating the status of hepatitis C infection based on the functional changes of hepatic stellate cells (Review)
Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
Difference in histological activity of non-tumorous liver tissue between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma without cirrhosis